VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
TECX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
TECXTectonic Therapeutic, Inc.
$33.09$624M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksTECXQuarterly Financials

Tectonic Therapeutic, Inc. (TECX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Tectonic Therapeutic, Inc. (TECX) quarterly income statement — complete revenue, gross profit & net income history

TECX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold000000000000920K0336K354K399K436K374K299K
COGS % of Revenue--------------------
Gross Profit000000000000-920K0-336K-354K-399K-436K-374K-299K
Gross Margin %--------------------
Gross Profit Growth %--------100%-100%100%-130.58%100%10.16%-18.39%-37.11%-41.1%-19.11%0.66%
Operating Expenses27.3M21.52M21.89M22.33M18.3M13.99M19.64M11.42M12.97M9.37M10.11M10.63M24.3M10.35M22.65M27.42M29.02M27.53M32.25M31.08M
OpEx % of Revenue--------------------
Selling, General & Admin6.43M5.17M4.96M5.15M5.26M4.83M5.32M4.35M2.15M2.18M1.98M1.86M7.29M2.07M7.07M8.9M10.16M8.96M9.58M8.83M
SG&A % of Revenue--------------------
Research & Development20.87M16.34M16.93M17.18M13.04M9.16M14.32M7.07M10.82M7.19M8.13M8.77M17M8.28M15.58M18.52M18.85M18.56M22.67M22.25M
R&D % of Revenue--------------------
Other Operating Expenses00000000000000000000
Operating Income-27.3M-21.52M-21.89M-22.33M-18.3M-13.99M-19.64M-11.42M-12.97M-9.37M-10.11M-10.63M-25.22M-10.35M-22.98M-27.77M-29.42M-27.96M-32.62M-31.38M
Operating Margin %--------------------
Operating Income Growth %-49.2%-53.78%-11.47%-95.53%-41.1%-49.25%-94.16%-7.43%48.58%9.39%56%61.72%14.27%63%29.54%11.48%-9.43%0.36%11.16%-8.73%
EBITDA-27.3M-20.82M-19.02M-21.99M-17.94M-13.48M-19.21M-11.09M-12.59M-9M-9.74M-10.41M-24.3M-10.02M-22.65M-27.42M-29.02M-27.53M-32.25M-31.08M
EBITDA Margin %--------------------
EBITDA Growth %-52.2%-54.44%1%-98.39%-42.47%-49.79%-97.2%-6.43%48.19%10.2%56.98%62.02%16.26%63.59%29.76%11.76%-9.12%0.83%11.42%-8.82%
D&A (Non-Cash Add-back)0693K0340K360K508K424K336K377K373K371K0920K322K336K354K399K436K374K299K
EBIT-27.3M-18.96M-19.02M-18.99M-15.89M-12.35M-17.69M-12.64M-15.19M-7.83M-10.02M-10.41M-24.96M-10.26M-22.97M-27.77M-29.46M-27.98M-32.61M-31.39M
Net Interest Income2.17M2.55M2.89M3.37M2.42M1.71M1.93M290K225K99K60K184K248K53K111K-285K-370K-245K2K9K
Interest Income2.18M2.56M2.9M3.39M2.44M1.74M1.95M318K256K133K96K224K248K87K111K0002K9K
Interest Expense8K12K14K17K20K22K25K28K31K34K36K40K034K0285K370K245K00
Other Income/Expense2.06M2.54M2.85M3.32M2.39M1.62M1.92M-1.25M-2.25M1.5M60K176K263K53K16K-280K-415K-265K7K-12K
Pretax Income-25.24M-18.97M-19.04M-19.01M-15.91M-12.37M-17.72M-12.67M-15.22M-7.87M-10.05M-10.46M-24.96M-10.29M-22.97M-28.05M-29.83M-28.23M-32.61M-31.39M
Pretax Margin %--------------------
Income Tax0254K0976K0000000000000000
Effective Tax Rate %0%-1.34%0%-5.13%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-25.24M-19.23M-19.04M-19.98M-15.91M-12.37M-17.72M-12.67M-15.22M-7.87M-10.05M-10.46M-24.96M-10.29M-22.97M-28.05M-29.83M-28.23M-32.61M-31.39M
Net Margin %--------------------
Net Income Growth %-58.69%-55.39%-7.44%-57.71%-4.5%-57.24%-76.22%-21.2%39.01%23.54%56.23%62.73%16.34%63.54%29.57%10.62%-10.91%-0.34%11.33%-8.88%
Net Income (Continuing)-25.24M-19.23M-19.04M-19.98M-15.91M-12.37M-17.72M-12.67M-15.22M-7.87M-10.05M-10.46M-24.96M-10.29M-22.97M-28.05M-29.83M-28.23M-32.61M-31.39M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-1.34-1.03-1.02-1.07-0.93-0.84-1.20-4.34-1.82-2.36-0.6818.29-6.80-6.86-6.30-7.70-8.19-7.76-8.97-8.84
EPS Growth %-44.09%-22.62%15%75.35%48.9%64.41%-76.47%-123.73%73.24%65.6%89.21%337.53%16.97%11.6%29.77%12.9%-5.54%11.42%25.93%7.72%
EPS (Basic)-1.34-1.03-1.02-1.07-0.93-0.84-1.20-4.34-1.82-2.36-0.6818.35-6.80-6.86-6.30-7.70-8.19-7.76-8.97-8.84
Diluted Shares Outstanding18.77M18.32M18.71M18.68M17.16M14.79M14.74M14.73M3.73M3.72M3.71M3.69M3.67M3.65M3.65M3.64M3.64M3.64M3.64M3.55M
Basic Shares Outstanding18.77M18.32M18.71M18.68M17.16M14.79M14.74M14.73M3.73M3.72M3.71M3.68M3.67M3.65M3.65M3.64M3.64M3.64M3.64M3.55M
Dividend Payout Ratio--------------------